Read Summary

“To any medical students and residents who have a spark for oncology, I cannot recommend the VMP enough,” said Zain Ahmad. “It is an experience that could change the trajectory of your career.”

When everyone is aligned with values and purpose in our societies and workplaces, we create spaces that put the well-being of all humans at the center, according to Prof. Sabe Sabesan, Anoj Sabesan, and Prof. Lynden Roberts.

Dr. Faye Lim describes her experience as a faculty member on multidisciplinary team management at events in Sarawak, Malaysia.

Dr. Ellen Zhang’s original poem was composed in honor of her grandmother and her patients.

This year’s recipients were indeed distinguished leaders in their fields and have dedicated their careers to improve diagnosis, outcomes, and quality of life as well advancing personalized therapy for patients. 

Dr. Shaalan Beg and Dr. Noelle LoConte consider how oncology organizations can balance the availability of alcoholic beverages at events with the evidence that alcohol consumption can increase cancer risk.

At the midpoint of her term as 2023-2024 ASCO president, Dr. Lynn M. Schuchter highlights key points of progress from 2023 and looks toward a busy year ahead.

Dr. Arcita Pramudita, Dr. Lintang Sagoro, Dr. Ardita Pramudani, and Dr. Polo Camacho discuss the many barriers in attempting to integrate palliative care in Indonesia, which include a lack of patient awareness and accessibility.

Happy new year—welcome to the first issue of your member magazine in 2024.

Dr. Tara Rajendran honors two women who, through their kindness and thoughtful attention, shaped her professional path from an early age.

“We all need to stay informed and engaged on the topic of AI in order to be the best advocates for ourselves, our profession, and our patients.”

Millions of people have been affected by the war in Sudan, and the outlook for patients with cancer is particularly dire. Dr. Nabeeha Karadawi, Dr. Salma Awad Elkareem Ali Mohamed, and Nagham Ali outline the current situation and call for immediate international aid.

If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.

“It takes courage to see people whom you have treated lose their lives when the disease takes the upper hand,” writes Dr. Pesona Grace Lucksom.

At a time when we are being asked, in every aspect of our work, to do more with less, we can expect streamlined, efficient, pragmatically designed clinical trials to play an increasingly important role in our research enterprise.

Dr. Narjust Florez, Dr. Fatima Wilder, Lauren Kiel, and Rebekah Kaufman underscore the need to comprehensively understand and address the unmet needs of young patients with lung cancer.

Dr. Joseph Merchant introduces the CPT process and recognizes ASCO colleagues who have represented the interests of members on this issue.

HemOncFellows Network organized an online discussion to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship application.

Print Friendly, PDF & Email